Related Experiment Videos
Amyloidosis in rheumatoid disease
Scandinavian Journal of Rheumatology. Supplement
|January 1, 1975
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pseudomonas aeruginosa infection in augmented care: the molecular ecology and transmission dynamics in four large UK hospitals.
The Journal of hospital infection·2021
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19.
Journal of internal medicine·2020
Improving patient outcomes with inguinal hernioplasty-local anaesthesia versus local anaesthesia and conscious sedation: a randomized controlled trial.
Hernia : the journal of hernias and abdominal wall surgery·2019
How should impaired morning function in rheumatoid arthritis be treated?
Scandinavian journal of rheumatology. Supplement·2011
Morning stiffness and other patient-reported outcomes of rheumatoid arthritis in clinical practice.
Scandinavian journal of rheumatology. Supplement·2011
How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.
Scandinavian journal of rheumatology. Supplement·2011
How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?
Scandinavian journal of rheumatology. Supplement·2011
Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis.
Scandinavian journal of rheumatology. Supplement·2011
Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease.
Scandinavian journal of rheumatology. Supplement·2011
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026